Numerate competitors

Satya Chava is a Chief Executive Officer at Aptuit and is based in Greenwich, CT area.

Technology and Payments EntrepreneurSpecialties: Electronic payments, prepaid, merchant processing both on and offline, global remittance processing, financial services technologies, rent and lease related payments processing, payments compliance, money transfer, mobile money transfer.

Elisabet De Los Pinos is a Board Member at Aura Biosciences and Founder & CEO at Aura Biosciences and is based in Cambridge, Massachusetts. She has worked as Brand Manager Oncology Business Unit at ELI LILLY & CO. Elisabet works or has worked as Post-Doctoral Fellow at Institute of Cancer Research/The. She studied at Institute of Cancer Research/The between 2000 and 2002, University of London between 2000 and 2002, and Icahn School of Medicine at Mount Sinai between 1999 and 1999.

Dr. Worland has served as a member of the board of directors since February 2015. Dr. Worland is currently President and Chief Executive Officer and a director of eFFECTOR Therapeutics, Inc., a company focused on new treatments for cancer, where he has served since May 2012. Previously, Dr. Worland was President and Chief Executive Officer and a director of Anadys Pharmaceuticals, Inc., a biopharmaceutical company which discovered and developed treatments for hepatitis C and cancer, from August 2007 until the company’s acquisition by Roche in November 2011. Dr. Worland joined Anadys in 2001 and served in a number of executive roles prior to being named Chief Executive Officer, including President, Pharmaceuticals, and Chief Scientific Officer. Dr. Worland began his healthcare industry career at Agouron Pharmaceuticals, Inc. and remained with the company through its successful commercialization of an HIV protease inhibitor and successive acquisitions by Warner-Lambert and Pfizer. During this period, Dr. Worland held a number of positions, including Vice President, Antiviral Research and Director, Molecular Biology and Biochemistry. Dr. Worland was a National Institutes of Health Postdoctoral Fellow in Molecular Biology at Harvard University. Dr. Worland received his B.S. with highest honors in Biological Chemistry from the University of Michigan and his Ph.D. in Chemistry from the University of California, Berkeley.